Dr Jean-Yves Maillard - BSc PhD
Member of the School's Drug Delivery & Microbiology Research Discipline
Research interests include:
- Efficacy of biocidal agents against micro-organisms
- Mechanisms of action of biocidal agents
- Mechanisms of microbial resistance and cross-resistance to antimicrobials
- Development of efficacy testing protocols
- New delivery systems for biocidal agents
Presentation by Dr Jean-Yves Maillard to the Infection Prevention Society, Cardiff 2011
Current Research Projects
Development of novel sporicidal formulations
Assessing the in vivo efficacy of sporicidal wipes
Bacterial resistance to biocides: an assessment of resistance mechanisms and method development.
Understanding the interactions of oxidizing agents with macromolecules and microbial cell components
Identification and validation of method(s) to describe antimicrobial resistance development
Detection of Lipopolysaccharide pyrogens by molecularly-imprinted polymers*
Collaborators
Postdoctoral Fellows
Dr Mark Legget (2011-2013) : Development of novel sporicidal formulations.
Gareth Williams (2006-2008) Surveillance of susceptibility profile to disinfectants in ITU isolates of Staphylococcus aureus including MRSA
Sukyul Jung (2006-2008) Ex-vivo modelling of antimicrobial control measures in pulpal disease
Key Expertise
- Biocide efficacy against micro-organisms including bacteria, viruses, bacterial endospores, protozoa
- Biocide efficacy standard test protocols
- Biocide interactions with microbial cells
- Development of microbial resistance to biocides and to chemotherapeutic antibiotics
- Design of efficacy test protocols including antimicrobial wipe efficacy test (link to wipe ppt)
Research Funding (current)
Efficacy of antimicrobial agents:
2012-2013 Dunhill Medical Trust (£50,523): Preventing dental pain, abscess and tooth loss in older adults: Development of antimicrobial restorative materials to manage dental disease in older adults
2012-2014 KTP (Cardiff University/GAMA Healthcare) (£138,000): Assessing the in vivo efficacy of sporicidal wipes – R&D development
2010-2013 NIHR (£241,5277): Biocide impregnated surface materials for use in clinical areas – under what conditions do they work?
2011-2013 KTP (Cardiff University/Steris) (£142,027): Development of novel sporicidal formulations
2009- GAMA Healthcare. Testing of the sporicidal activity of commercially available wipes against Clostridium difficile
Molecular mechanisms of action of, and resistance to, antimicrobial agents:
2008-2011 Steris Corporation, UK/WSOP (£34,000): Understanding the interactions of oxidizing agents with macromolecules and microbial cell components
Effects of biocides on the transfer of antibiotic-resistant genes & linkage between antibiotic & biocide resistance in bacteria:
2011-2014 Unilever (£112,332): Bacterial resistance to biocides: an assessment of resistance mechanisms and method development.
2012 L’Oréal, Paris. Preliminary testing of the propensity of preservative molecules to induce/select/trigger bacterial resistance
2010-2013 Unilever (£105,765): Identification and validation of method(s) to describe antimicrobial resistance development
